Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Overactive Bladder
IRCT20210212050333N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in overactive bladder (OAB), sponsored by Arak University of Medical Sciences. Started Jun 2021; status: completed.
02
Drugs
montelukast
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on IRCT20210212050333N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210212050333N1.